{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:37:56Z","timestamp":1786538276116,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR074436"],"award-info":[{"award-number":["R01AR074436"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD109335"],"award-info":[{"award-number":["R01HD109335"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR003017, UM1TR004789"],"award-info":[{"award-number":["UL1TR003017, UM1TR004789"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-026-03842-6","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:35:48Z","timestamp":1780878948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recent antibiotic exposure and response to treatment of juvenile idiopathic arthritis: a retrospective cohort study"],"prefix":"10.1186","volume":"28","author":[{"given":"Daniel B.","family":"Horton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charu","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanika","family":"Rege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Gerhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Iizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Iozzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Koffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Parlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos D.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Strom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"9563","key":"3842_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369(9563):767\u201378.","journal-title":"Lancet"},{"issue":"2","key":"3842_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra2402073","volume":"393","author":"CI Sandborg","year":"2025","unstructured":"Sandborg CI, Schulert GS, Kimura Y. Juvenile Idiopathic Arthritis. N Engl J Med. 2025;393(2):162\u201374.","journal-title":"N Engl J Med"},{"issue":"4","key":"3842_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.rdc.2021.07.009","volume":"47","author":"K Onel","year":"2021","unstructured":"Onel K, Rumsey DG, Shenoi S. Juvenile Idiopathic Arthritis Treatment Updates. Rheum Dis Clin North Am. 2021;47(4):545\u201363.","journal-title":"Rheum Dis Clin North Am"},{"issue":"11","key":"3842_CR4","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/art.41390","volume":"72","author":"HI Brunner","year":"2020","unstructured":"Brunner HI, Schanberg LE, Kimura Y, et al. New Medications Are Needed for Children With Juvenile Idiopathic Arthritis. Arthritis Rheumatol. 2020;72(11):1945\u201351.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"3842_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.rdc.2025.01.005","volume":"51","author":"LD Cole","year":"2025","unstructured":"Cole LD, Kuhn KA. It Takes a Village: Juvenile Idiopathic Arthritis and the Microbiome. Rheum Dis Clin North Am. 2025;51(2):233\u201382.","journal-title":"Rheum Dis Clin North Am"},{"issue":"6","key":"3842_CR6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s13075-014-0486-0","volume":"16","author":"ML Stoll","year":"2014","unstructured":"Stoll ML, Kumar R, Morrow CD, et al. Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis. Arthritis Res Ther. 2014;16(6):486.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"3842_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10096-015-2548-x","volume":"35","author":"MV Tejesvi","year":"2016","unstructured":"Tejesvi MV, Arvonen M, Kangas SM, et al. Faecal microbiome in new-onset juvenile idiopathic arthritis. Eur J Clin Microbiol Infect Dis. 2016;35(3):363\u201370.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"3842_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13075-018-1510-6","volume":"20","author":"ML Stoll","year":"2018","unstructured":"Stoll ML, Weiss PF, Weiss JE, et al. Age and fecal microbial strain-specific differences in patients with spondyloarthritis. Arthritis Res Ther. 2018;20(1):14.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"3842_CR9","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/art.40827","volume":"71","author":"EHP van Dijkhuizen","year":"2019","unstructured":"van Dijkhuizen EHP, Del Chierico F, Malattia C, et al. Microbiome Analytics of the Gut Microbiota in Patients With Juvenile Idiopathic Arthritis: A Longitudinal Observational Cohort Study. Arthritis Rheumatol. 2019;71(6):1000\u201310.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"3842_CR10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12864-020-6703-0","volume":"21","author":"X Qian","year":"2020","unstructured":"Qian X, Liu YX, Ye X, et al. Gut microbiota in children with juvenile idiopathic arthritis: characteristics, biomarker identification, and usefulness in clinical prediction. BMC Genomics. 2020;21(1):286.","journal-title":"BMC Genomics"},{"key":"3842_CR11","doi-asserted-by":"publisher","first-page":"104654","DOI":"10.1016\/j.ebiom.2023.104654","volume":"93","author":"E Kindgren","year":"2023","unstructured":"Kindgren E, Ahrens AP, Triplett EW, Ludvigsson J. Infant gut microbiota and environment associate with juvenile idiopathic arthritis many years prior to disease onset, especially in genetically vulnerable children. EBioMedicine. 2023;93:104654.","journal-title":"EBioMedicine"},{"issue":"3","key":"3842_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3899\/jrheum.140348","volume":"42","author":"M Arvonen","year":"2015","unstructured":"Arvonen M, Virta LJ, Pokka T, Kroger L, Vahasalo P. Repeated exposure to antibiotics in infancy: a predisposing factor for juvenile idiopathic arthritis or a sign of this group\u2019s greater susceptibility to infections? J Rheumatol. 2015;42(3):521\u20136.","journal-title":"J Rheumatol"},{"issue":"2","key":"3842_CR13","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1542\/peds.2015-0036","volume":"136","author":"DB Horton","year":"2015","unstructured":"Horton DB, Scott FI, Haynes K, et al. Antibiotic Exposure and Juvenile Idiopathic Arthritis: A Case-Control Study. Pediatrics. 2015;136(2):e333\u2013343.","journal-title":"Pediatrics"},{"key":"3842_CR14","doi-asserted-by":"crossref","unstructured":"Hestetun S, Andersen S, Sanner H, Stordal K. Antibiotic exposure in prenatal and early life and risk of juvenile idiopathic arthritis: a nationwide register-based cohort study. RMD Open. 2023;9(3):e003333.","DOI":"10.1136\/rmdopen-2023-003333"},{"issue":"5","key":"3842_CR15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41584-020-0395-3","volume":"16","author":"JU Scher","year":"2020","unstructured":"Scher JU, Nayak RR, Ubeda C, Turnbaugh PJ, Abramson SB. Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response. Nat Rev Rheumatol. 2020;16(5):282\u201392.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"3842_CR16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/art.41622","volume":"73","author":"A Artacho","year":"2021","unstructured":"Artacho A, Isaac S, Nayak R, et al. The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New-Onset Rheumatoid Arthritis. Arthritis Rheumatol. 2021;73(6):931\u201342.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"3842_CR17","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1093\/rheumatology\/keac458","volume":"62","author":"J Qiao","year":"2023","unstructured":"Qiao J, Zhang SX, Chang MJ, et al. Specific enterotype of gut microbiota predicted clinical effect of methotrexate in patients with rheumatoid arthritis. Rheumatology (Oxford). 2023;62(3):1087\u201396.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"3842_CR18","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1002\/art.34458","volume":"64","author":"T Beukelman","year":"2012","unstructured":"Beukelman T, Xie F, Chen L, et al. Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum. 2012;64(8):2773\u201380.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"3842_CR19","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1136\/annrheumdis-2017-212613","volume":"77","author":"T Beukelman","year":"2018","unstructured":"Beukelman T, Xie F, Chen L, et al. Risk of malignancy associated with paediatric use of tumour necrosis factor inhibitors. Ann Rheum Dis. 2018;77(7):1012\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3842_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/aje\/kwaa197","volume":"190","author":"DB Horton","year":"2021","unstructured":"Horton DB, Xie F, Chen L, et al. Oral Glucocorticoids and Incident Treatment of Diabetes Mellitus, Hypertension, and Venous Thromboembolism in Children. Am J Epidemiol. 2021;190(3):403\u201312.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"3842_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/RHU.0000000000002035","volume":"29","author":"DB Horton","year":"2023","unstructured":"Horton DB, Yang Y, Neikirk A, et al. Impact of the COVID-19 Pandemic on the Management of Juvenile Idiopathic Arthritis: Analysis of United States Commercial Insurance Data. J Clin Rheumatol. 2023;29(8):388\u201395.","journal-title":"J Clin Rheumatol"},{"key":"3842_CR22","unstructured":"Horton DB, Parlett LE, Zhu Y et al. External validation of claims-based algorithms for newly diagnosed juvenile idiopathic arthritis [abstract]. Arthritis Rheumatol 2025;77(suppl 9)."},{"issue":"7698","key":"3842_CR23","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nature25979","volume":"555","author":"L Maier","year":"2018","unstructured":"Maier L, Pruteanu M, Kuhn M, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018;555(7698):623\u20138.","journal-title":"Nature"},{"issue":"5","key":"3842_CR24","doi-asserted-by":"publisher","first-page":"e5803","DOI":"10.1002\/pds.5803","volume":"33","author":"K Saito","year":"2024","unstructured":"Saito K, Gabbeta A, Mulvihill E, et al. Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis. Pharmacoepidemiol Drug Saf. 2024;33(5):e5803.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3842_CR25","doi-asserted-by":"publisher","first-page":"1712103","DOI":"10.3389\/fimmu.2025.1712103","volume":"16","author":"YC Hu","year":"2025","unstructured":"Hu YC, Huang YL, Yiao SY, Lin MT, Lin FJ, Yang YH. The epidemiology and biologics treatment patterns of juvenile idiopathic arthritis in Taiwan- an 8-year follow-up. Front Immunol. 2025;16:1712103.","journal-title":"Front Immunol"},{"issue":"7","key":"3842_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1542\/hpeds.2016-0173","volume":"7","author":"TD Simon","year":"2017","unstructured":"Simon TD, Cawthon ML, Popalisky J, Mangione-Smith R. Center of Excellence on Quality of Care Measures for Children with Complex N. Development and Validation of the Pediatric Medical Complexity Algorithm (PMCA) Version 2.0. Hosp Pediatr. 2017;7(7):373\u20137.","journal-title":"Hosp Pediatr"},{"issue":"5","key":"3842_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrmicro.2016.17","volume":"14","author":"P Spanogiannopoulos","year":"2016","unstructured":"Spanogiannopoulos P, Bess EN, Carmody RN, Turnbaugh PJ. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol. 2016;14(5):273\u201387.","journal-title":"Nat Rev Microbiol"},{"key":"3842_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.trsl.2016.08.002","volume":"179","author":"ID Wilson","year":"2017","unstructured":"Wilson ID, Nicholson JK. Gut microbiome interactions with drug metabolism, efficacy, and toxicity. Transl Res. 2017;179:204\u201322.","journal-title":"Transl Res"},{"key":"3842_CR29","first-page":"10","volume":"69","author":"RR Nayak","year":"2017","unstructured":"Nayak RR, Stapleton-Gray K, O\u2019Loughlin C, Fischbach M, Turnbaugh PJ. Methotrexate Is an antibacterial drug metabolized by human gut bacteria [abstract]. Arthritis Rheumatol. 2017;69:10.","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"3842_CR30","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1097\/MIB.0000000000001228","volume":"23","author":"N Narula","year":"2017","unstructured":"Narula N, Kassam Z, Yuan Y, et al. Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis. Inflamm Bowel Dis. 2017;23(10):1702\u20139.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"3842_CR31","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/ibd\/izx035","volume":"24","author":"A Goyal","year":"2018","unstructured":"Goyal A, Yeh A, Bush BR, et al. Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2018;24(2):410\u201321.","journal-title":"Inflamm Bowel Dis"},{"key":"3842_CR32","doi-asserted-by":"crossref","unstructured":"Qin P, Kragsnaes MS, Holm DK et al. Clinical significance of gut microbiota community types for long-term response to fecal microbiota transplantation in patients with psoriatic arthritis. Arthritis Rheumatol. 2026;78(2):320\u201331.","DOI":"10.1002\/art.43359"},{"issue":"5","key":"3842_CR33","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s10067-025-07421-z","volume":"44","author":"N Hagstrom","year":"2025","unstructured":"Hagstrom N, Oman A, Koochek A, Arnell H, Berntson L. One-year follow-up of a short specific carbohydrate diet intervention in children with juvenile idiopathic arthritis: A retrospectively controlled study with focus on medical burden. Clin Rheumatol. 2025;44(5):2031\u201341.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"3842_CR34","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/cei.12900","volume":"187","author":"A Aggarwal","year":"2017","unstructured":"Aggarwal A, Sarangi AN, Gaur P, Shukla A, Aggarwal R. Gut microbiome in children with enthesitis-related arthritis in a developing country and the effect of probiotic administration. Clin Exp Immunol. 2017;187(3):480\u20139.","journal-title":"Clin Exp Immunol"},{"issue":"02","key":"3842_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1055\/s-0037-1601340","volume":"12","author":"P Hissink Muller","year":"2017","unstructured":"Hissink Muller P, de Meij TGJ, Westedt M, et al. Disturbance of Microbial Core Species in New-Onset Juvenile Idiopathic Arthritis. J Pediatr Infect Dis. 2017;12(02):131\u20135.","journal-title":"J Pediatr Infect Dis"},{"key":"3842_CR36","doi-asserted-by":"publisher","first-page":"700570","DOI":"10.3389\/fimmu.2021.700570","volume":"12","author":"Z Chen","year":"2021","unstructured":"Chen Z, Zheng X, Wu X, et al. Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis. Front Immunol. 2021;12:700570.","journal-title":"Front Immunol"},{"issue":"5","key":"3842_CR37","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1002\/art.37866","volume":"65","author":"T Beukelman","year":"2013","unstructured":"Beukelman T, Xie F, Baddley JW, et al. Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis. Arthritis Rheum. 2013;65(5):1384\u20139.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3842_CR38","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13075-016-1109-8","volume":"18","author":"T Beukelman","year":"2016","unstructured":"Beukelman T, Xie F, Baddley JW, et al. The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis. Arthritis Res Ther. 2016;18(1):210.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"3842_CR39","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00296-020-04774-3","volume":"41","author":"F Thiele","year":"2021","unstructured":"Thiele F, Klein A, Windschall D, et al. Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry. Rheumatol Int. 2021;41(4):751\u201362.","journal-title":"Rheumatol Int"},{"issue":"5","key":"3842_CR40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/pds.1200","volume":"15","author":"S Schneeweiss","year":"2006","unstructured":"Schneeweiss S. Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics. Pharmacoepidemiol Drug Saf. 2006;15(5):291\u2013303.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3842_CR41","volume-title":"Pharmacoepidemiology Sixth ed","year":"2019","unstructured":"Strom BL, Kimmel SE, Hennessy S, editors. Pharmacoepidemiology. Sixth ed. Oxford, UK: Wiley-Blackwell; 2019."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03842-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03842-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03842-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:04:42Z","timestamp":1786536282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03842-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3842"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03842-6","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the New England Institutional Review Board (IRB) (now WCG IRB) (#1294354) and Rutgers IRB (Pro2021002022). A waiver for consent was approved by the IRBs for this retrospective study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Horton has received research funding from Danisco USA Inc. Dr. Gerhard has consulted for Alkermes, Eisai, and Intracellular Products, Lundbeck, and Pharmacosmos. Therapies. Dr. Parlett works at Carelon Research, a subsidiary of Elevance Health and has received research funding from Bristol-Myers Squibb, Novartis, Pfizer, and Teva. Dr. Rose has consulted for Abbvie, Novartis, and the US Department of Health & Human Services. Dr. Strom has consulted for Abbvie, Consumer Healthcare Products Association, Johnson & Johnson Consumer. The other authors report no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"150"}}